Approval · Notice of Compliance 25401 · 2021
CEFADROXIL: Notice of Compliance 25401
Issued March 9, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25401
- Date
- March 9, 2021
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the product monograph
- Canadian reference product
- DURICEF (Bristol-Myers Squibb Canada)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEFADROXIL | Not yet assigned | — |
Medicinal ingredients
- CEFADROXIL 500 MG per CAP